10-Q/A Filing

SUPERNUS PHARMACEUTICALS, INC. CIK: 1356576 Q3 2015

Filing Information

Form Type	10-Q/A
Accession Number	`0001104659-17-003384`
Period End Date	20150930
Filing Date	20170120
Fiscal Year	2015
Fiscal Period	Q3
XBRL Instance	supn-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 98 Income Statement 90 Cash Flow Statement 78 Comprehensive Income 16

Balance Sheet 98 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	130.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	130.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	130.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.69M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	42.93M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.64M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$37.78M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	42.97M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$36.40M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$37.94M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	42.93M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$32.06M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$34.78M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.69M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	42.97M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$23.60M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$15.30M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$17.27M	USD	Point-in-time
Inventories, net	`InventoryNet`	$13.44M	USD	Point-in-time
Inventories, net	`InventoryNet`	$11.14M	USD	Point-in-time
Inventories, net	`InventoryNet`	$14.74M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.79M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.47M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.68M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$102.52M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$108.73M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$102.80M	USD	Point-in-time
Long term marketable securities	`MarketableSecuritiesNoncurrent`	$43.97M	USD	Point-in-time
Long term marketable securities	`MarketableSecuritiesNoncurrent`	$19.82M	USD	Point-in-time
Long term marketable securities	`MarketableSecuritiesNoncurrent`	$15.76M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.50M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.21M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.45M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.43M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.13M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$16.63M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$360.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$322.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$360.00K	USD	Point-in-time
Total assets	`Assets`	$166.64M	USD	Point-in-time
Total assets	`Assets`	$136.78M	USD	Point-in-time
Total assets	`Assets`	$125.56M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.57M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.86M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.81M	USD	Point-in-time
Accrued sales deductions	`AccruedSalesDeduction`	$8.46M	USD	Point-in-time
Accrued sales deductions	`AccruedSalesDeduction`	$7.30M	USD	Point-in-time
Accrued sales deductions	`AccruedSalesDeduction`	$18.82M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$13.11M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$17.66M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$21.65M	USD	Point-in-time
Non-recourse liability related to sale of future royalties- current portion	`NonRecourseDebtSaleOfFutureRoyaltiesCurrent`	$261.00K	USD	Point-in-time
Deferred licensing revenue	`DeferredRevenueLicensingCurrent`	$143.00K	USD	Point-in-time
Deferred licensing revenue	`DeferredRevenueLicensingCurrent`	$143.00K	USD	Point-in-time
Deferred licensing revenue	`DeferredRevenueLicensingCurrent`	$143.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$43.69M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$22.13M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$28.12M	USD	Point-in-time
Deferred licensing revenue, net of current portion	`DeferredRevenueLicensingNoncurrent`	$1.27M	USD	Point-in-time
Deferred licensing revenue, net of current portion	`DeferredRevenueLicensingNoncurrent`	$1.17M	USD	Point-in-time
Deferred licensing revenue, net of current portion	`DeferredRevenueLicensingNoncurrent`	$1.31M	USD	Point-in-time
Convertible notes, net of discount	`ConvertibleLongTermNotesPayable`	$7.94M	USD	Point-in-time
Convertible notes, net of discount	`ConvertibleLongTermNotesPayable`	$25.73M	USD	Point-in-time
Convertible notes, net of discount	`ConvertibleLongTermNotesPayable`	$26.22M	USD	Point-in-time
Non-recourse liability related to sale of future royalties-long term	`NonRecourseDebtSaleOfFutureRoyaltiesNoncurrent`	$30.29M	USD	Point-in-time
Non-recourse liability related to sale of future royalties-long term	`NonRecourseDebtSaleOfFutureRoyaltiesNoncurrent`	$30.02M	USD	Point-in-time
Non-recourse liability related to sale of future royalties-long term	`NonRecourseDebtSaleOfFutureRoyaltiesNoncurrent`	$30.13M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.81M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.88M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.02M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$1.16M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$7.26M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$6.56M	USD	Point-in-time
Total liabilities	`Liabilities`	$88.05M	USD	Point-in-time
Total liabilities	`Liabilities`	$96.08M	USD	Point-in-time
Total liabilities	`Liabilities`	$89.57M	USD	Point-in-time
Common stock, $0.001 par value, 130,000,000 shares authorized at September 30, 2015, December 31, 2014 and September 30, 2014; 48,686,657, 42,974,463 and 42,929,826 shares issued and outstanding at September 30, 2015, December 31, 2014 and September 30, 2014, respectively	`CommonStockValue`	$43.00K	USD	Point-in-time
Common stock, $0.001 par value, 130,000,000 shares authorized at September 30, 2015, December 31, 2014 and September 30, 2014; 48,686,657, 42,974,463 and 42,929,826 shares issued and outstanding at September 30, 2015, December 31, 2014 and September 30, 2014, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Common stock, $0.001 par value, 130,000,000 shares authorized at September 30, 2015, December 31, 2014 and September 30, 2014; 48,686,657, 42,974,463 and 42,929,826 shares issued and outstanding at September 30, 2015, December 31, 2014 and September 30, 2014, respectively	`CommonStockValue`	$43.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$261.01M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$230.26M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$229.22M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-107.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-154.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-35.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-193.24M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-182.36M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-189.45M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$40.70M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$35.99M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$78.59M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$166.64M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$125.56M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$136.78M	USD	Point-in-time

Income Statement 90 line items

Line Item	Tag	Value	Unit	Period
Net product sales	`SalesRevenueNet`	$100.91M	USD	3 Qtrs
Net product sales	`SalesRevenueNet`	$59.06M	USD	3 Qtrs
Net product sales	`SalesRevenueNet`	$38.55M	USD	1 Quarter
Net product sales	`SalesRevenueNet`	$22.45M	USD	1 Quarter
Royalty revenue	`RoyaltyRevenue`	$199.00K	USD	3 Qtrs
Royalty revenue	`RoyaltyRevenue`	$199.00K	USD	1 Quarter
Royalty revenue	`RoyaltyRevenue`	$776.00K	USD	1 Quarter
Royalty revenue	`RoyaltyRevenue`	$2.01M	USD	3 Qtrs
Licensing revenue	`LicensesRevenue`	$857.00K	USD	3 Qtrs
Licensing revenue	`LicensesRevenue`	$35.00K	USD	1 Quarter
Licensing revenue	`LicensesRevenue`	$2.19M	USD	3 Qtrs
Licensing revenue	`LicensesRevenue`	$36.00K	USD	1 Quarter
Total revenue	`Revenues`	$61.44M	USD	3 Qtrs
Total revenue	`Revenues`	$39.36M	USD	1 Quarter
Total revenue	`Revenues`	$103.78M	USD	3 Qtrs
Total revenue	`Revenues`	$22.69M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$5.63M	USD	3 Qtrs
Cost of product sales	`CostOfGoodsSold`	$1.32M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$3.48M	USD	3 Qtrs
Cost of product sales	`CostOfGoodsSold`	$2.25M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$19.69M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$13.82M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$9.13M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.66M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$54.55M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$17.45M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$22.90M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$65.50M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$71.85M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$23.42M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$90.81M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$34.28M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$12.96M	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-10.40M	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$5.08M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-736.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$265.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$419.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$169.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$78.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.29M	USD	1 Quarter
Interest expense	`InterestExpense`	$292.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$3.77M	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.00M	USD	3 Qtrs
Interest expense - non-recourse liability related to sale of future royalties	`InterestExpenseNonRecourseRoyaltyLiability`	$2.53M	USD	3 Qtrs
Interest expense - non-recourse liability related to sale of future royalties	`InterestExpenseNonRecourseRoyaltyLiability`	$998.00K	USD	1 Quarter
Interest expense - non-recourse liability related to sale of future royalties	`InterestExpenseNonRecourseRoyaltyLiability`	$326.00K	USD	1 Quarter
Interest expense - non-recourse liability related to sale of future royalties	`InterestExpenseNonRecourseRoyaltyLiability`	$326.00K	USD	3 Qtrs
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$2.12M	USD	3 Qtrs
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$760.00K	USD	1 Quarter
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$114.00K	USD	1 Quarter
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$66.00K	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-25.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.59M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-860.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.40M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$30.00K	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$5.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$2.00K	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-5.42M	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-1.03M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-1.64M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-4.31M	USD	3 Qtrs
Earnings (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-14.71M	USD	3 Qtrs
Earnings (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.37M	USD	1 Quarter
Earnings (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.54M	USD	3 Qtrs
Earnings (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.06M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$142.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$453.00K	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-2.37M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-14.71M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$7.09M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$3.92M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.15	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.35	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.08	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.06	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.08	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.06	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.15	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.35	USD	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	42.90M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.52M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	42.04M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	47.01M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	42.90M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	51.06M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	51.59M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	42.04M	shares	3 Qtrs

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-2.37M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-14.71M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$7.09M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$3.92M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-25.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.59M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-860.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.40M	USD	3 Qtrs
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$66.00K	USD	3 Qtrs
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$2.12M	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments`	$35.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments`	$-47.00K	USD	3 Qtrs
Non-cash interest expense/income on liability related to sale of future royalties	`InterestExpenseNonRecourseRoyaltyLiability`	$326.00K	USD	1 Quarter
Non-cash interest expense/income on liability related to sale of future royalties	`InterestExpenseNonRecourseRoyaltyLiability`	$326.00K	USD	3 Qtrs
Non-cash interest expense/income on liability related to sale of future royalties	`InterestExpenseNonRecourseRoyaltyLiability`	$998.00K	USD	1 Quarter
Non-cash interest expense/income on liability related to sale of future royalties	`InterestExpenseNonRecourseRoyaltyLiability`	$2.53M	USD	3 Qtrs
Non-cash royalty revenue	`RoyaltyRevenue`	$2.01M	USD	3 Qtrs
Non-cash royalty revenue	`RoyaltyRevenue`	$776.00K	USD	1 Quarter
Non-cash royalty revenue	`RoyaltyRevenue`	$199.00K	USD	3 Qtrs
Non-cash royalty revenue	`RoyaltyRevenue`	$199.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$651.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$701.00K	USD	3 Qtrs
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$646.00K	USD	3 Qtrs
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$1.60M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$3.01M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$2.12M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$6.33M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$10.25M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$1.30M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$3.99M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.79M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.26M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$949.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.58M	USD	3 Qtrs
Accounts sales deductions	`IncreaseDecreaseInAccountsSalesDeductions`	$4.35M	USD	3 Qtrs
Accounts sales deductions	`IncreaseDecreaseInAccountsSalesDeductions`	$10.36M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-459.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-598.00K	USD	3 Qtrs
Deferred product revenue, net	`IncreaseDecreaseInDeferredProductRevenueNet`	$-7.88M	USD	3 Qtrs
Deferred licensing revenue	`IncreaseDecreaseInDeferredLicensingRevenue`	$-107.00K	USD	3 Qtrs
Deferred licensing revenue	`IncreaseDecreaseInDeferredLicensingRevenue`	$-168.00K	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-21.00K	USD	3 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$337.00K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$14.60M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-30.76M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$51.94M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$34.57M	USD	3 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$33.67M	USD	3 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$41.99M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$475.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.24M	USD	3 Qtrs
Deferred legal fees	`IncreaseDecreaseInDeferredLegalFees`	$1.65M	USD	3 Qtrs
Deferred legal fees	`IncreaseDecreaseInDeferredLegalFees`	$6.91M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-26.42M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$5.29M	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$265.00K	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.07M	USD	3 Qtrs
Cash settlement of debt to equity conversion	`RepaymentsOfConvertibleDebt`	$1.00K	USD	3 Qtrs
Proceeds from sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	$30.00M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.07M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$30.26M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.80M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-10.76M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$37.78M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$36.40M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$25.64M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$25.64M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$36.40M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$37.78M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$504.00K	USD	3 Qtrs
Cash paid for interest	`InterestPaid`	$1.50M	USD	3 Qtrs
Conversion of convertible notes and interest make-whole	`DebtConversionConvertedInstrumentAmount1`	$14.89M	USD	3 Qtrs
Conversion of convertible notes and interest make-whole	`DebtConversionConvertedInstrumentAmount1`	$26.02M	USD	3 Qtrs
Exercise of warrants	`ExerciseOfWarrantsAmountExercised`	$652.00K	USD	3 Qtrs
Deferred legal fees included in accrued expenses	`NonCashCapitalizedCostOfIntangibleAssets`	$6.87M	USD	3 Qtrs
Deferred legal fees included in accrued expenses	`NonCashCapitalizedCostOfIntangibleAssets`	$1.50M	USD	3 Qtrs

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-2.37M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-14.71M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$7.09M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$3.92M	USD	1 Quarter
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$47.00K	USD	3 Qtrs
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-36.00K	USD	1 Quarter
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$44.00K	USD	1 Quarter
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-35.00K	USD	3 Qtrs
Other comprehensive income (loss):	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$47.00K	USD	3 Qtrs
Other comprehensive income (loss):	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-35.00K	USD	3 Qtrs
Other comprehensive income (loss):	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-36.00K	USD	1 Quarter
Other comprehensive income (loss):	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$44.00K	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-14.75M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-2.41M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$3.96M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$7.14M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.